Pemetrexed Disodium With or Without Sorafenib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Clinical trial NCT00454194 · COMPLETED

Trial details

NCT number

NCT00454194

Sponsor

Alliance for Clinical Trials in Oncology

Status

COMPLETED

Phase

Phase 2

Study type

INTERVENTIONAL

Start date

2007-09-01

Primary completion

2010-07-01

Enrollment

110

View on ClinicalTrials.gov